Kabra Drugs Ltd Share Price
As on 18 July 2026 at 17:04 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-19.98%
Over 6 Months
-25.07%
Over 1 Year
75.51%
Over 3 Years
296.85%
Kabra Drugs Ltd Summary
Close ₹21.43
Open ₹21
High ₹22.81
Low ₹20.50
Volume 59,256
Net Turnover (in Cr) ₹0.12
52Wk High ₹35.52
52Wk Low ₹12.21
52Wk High / Low
12.21
35.52
Kabra Drugs Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹50.81
EPS (TTM) 2.09
Book Value (BV) 12.49
Div. Yield -
P/E (TTM) 10.25
Price/Book Value 1.72
Delivery % 74.03 %
Face Value 10
Key Ratios
PE Ratio -
PB Ratio 1.07
EV to Sales -
PEG Ratio -
ROA -4.34
ROE -
Debt-Equity 0.08
Net Profit Margin -
Operating Profit Margin -
Kabra Drugs Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.64 | - | 0.01 | - | - |
| Total Expenses | 1.73 | 0.74 | 0.34 | 0.19 | 0.18 |
| Profit Before Tax | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| Profit After Tax | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| Operating Profit After Depreciation | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 0.04 | - | - | - | 0.01 |
| Total Non Current Assets | 0.07 | 0.02 | 0.02 | 0.02 | 0.03 |
| Total Current Assets | 25.16 | 4.55 | 0.68 | 0.71 | 1.37 |
| Total Assets | 25.23 | 4.57 | 0.70 | 0.73 | 1.40 |
| Total Shareholder's Fund | 24.65 | 1.08 | -0.73 | -0.39 | -0.21 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -4.71 | -0.21 | -0.35 | -0.13 | -0.25 |
| Net Cash Used In Investing Activities | -0.05 | - | - | - | - |
| Net Cash Used In Financing Activities | 23.39 | 2.88 | 0.36 | 0.13 | 0.25 |
No data available
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 35.41 | 30.42 | 19.76 | 7.15 | - |
| Total Expenses | 34.06 | 27.99 | 17.73 | 7.67 | 0.24 |
| Profit Before Tax | 1.43 | 2.60 | 2.20 | -0.50 | 0.39 |
| Profit After Tax | 1.06 | 2.57 | 1.84 | -0.50 | 0.39 |
| Operating Profit after Depreciation | 1.46 | 2.61 | 2.21 | -0.50 | 0.40 |
Kabra Drugs Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 20.35
S2 19.27
S3 18.04
Pivot 21.58
R1 22.66
R2 23.89
R3 24.97
Moving Average
20 SMA 23.51
50 SMA 25.24
100 SMA 27.50
200 SMA 25.13
Kabra Drugs Ltd Corporate Actions
No available data
Kabra Drugs Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Kabra Drugs Ltd Top Mutal Funds Invested
No data available
Kabra Drugs Ltd News
Kabra Drugs to conduct board meeting
On 29 May 2026
22 May 2026, 05:38 pm
Kabra Drugs to hold board meeting
On 6 May 2026
28 Apr 2026, 04:33 pm
Kabra Drugs to convene board meeting
On 21 April 2026
11 Apr 2026, 09:31 am
Kabra Drugs schedules board meeting
On 7 March 2026
27 Feb 2026, 10:01 am
Kabra Drugs to discuss results
On 13 February 2026
06 Feb 2026, 04:35 pm
Kabra Drugs Ltd Stock Analysis
- Annual revenue for Kabra Drugs Ltd remains unchanged by 0.00% to ₹0.64 crore in FY 2025 from ₹0 crore in FY 2024.
- Annual Net Profit for Kabra Drugs Ltd increased by 47.48% to ₹-1.09 crore in FY 2025 from ₹-0.74 crore in FY 2024.
- Promoter Shareholding in Kabra Drugs Ltd remains unchanged by 0.00% in the most recent quarter, from 0% in December 2025 to 0% in March 2026.
- Kabra Drugs Ltd delivered a 1-year return of 75.51% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Kabra Drugs Ltd share price moved up by 3.59% from its previous close of INR ₹21.43. The latest Kabra Drugs Ltd share price is INR ₹22.20.
- Kabra Drugs Ltd share price today has been at a low of 21.75 and a high of 22.51. Over the past 52 weeks, the Kabra Drugs Ltd share price has seen a low of 12.21 and a high of 35.52.
FAQ’s
What is the share price of Kabra Drugs Ltd today?
Kabra Drugs Ltd share price as on 18 Jul 2026 is ₹ 22.2
What is the Market Cap of Kabra Drugs Ltd?
The market cap of Kabra Drugs Ltd stock is ₹50.81 Cr.
What is the PE Ratio of Kabra Drugs Ltd?
The Price to Earnings (P/E) Ratio of Kabra Drugs Ltd is -
What is the PB Ratio of Kabra Drugs Ltd?
The Price to Book (P/B) Ratio of Kabra Drugs Ltd is 1.07
What is the 52 week high of Kabra Drugs Ltd Share Price?
The 52 week high of Kabra Drugs Ltd share price stands at ₹35.52
What is the 52 week low of Kabra Drugs Ltd Share Price?
The 52 week low of Kabra Drugs Ltd share price stands at ₹12.21
How can I buy shares of Kabra Drugs Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Kabra Drugs Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
